PRIME importance of pathology expertise

Nature Biotechnology

Volumn 27, Issue 1, 2009, Pages 24-25

  Schofield, Paul N ^a   Brown, Steve D M ^b   Sundberg, John P ^c   Arends, Mark ^a   Warren, Madhuri V ^d,e   Dubus, Pierre ^f   Ellender, Michele ^g   Fiette, Laurence ^h   Rozell, Bjorn ⁱ   Quintanilla Martinez, Leticia ^j   Raspa, Marcello ^k   Song, Ji Ying ^l   Van Der Valk, Martin ^l   McKerlie, Colin ^m  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MRC MAMMALIAN GENETICS UNIT   (United Kingdom)

^c JACKSON LABORATORY   (United States)

^d PETERBOROUGH DISTRICT HOSPITAL   (United Kingdom)

^e ST JOHN S COLLEGE   (United Kingdom)

^f UNIVERSITÉ DE BORDEAUX   (France)

^g PUBLIC HEALTH ENGLAND   (United Kingdom)

^h INSTITUT PASTEUR   (France)

ⁱ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^j UNIVERSITY OF TÜBINGEN   (Germany)

^k CNR   (Italy)

^l NETHERLANDS CANCER INSTITUTE   (Netherlands)

^m MOUNT SINAI HOSPITAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; COMMUNITY; FUNDING; GENOME; HISTOPATHOLOGY; LETTER; MUTANT; NONHUMAN; PATHOLOGY; PERCEPTION; PHENOTYPE; PRIORITY JOURNAL; QUESTIONNAIRE;

ANIMALS; BIOTECHNOLOGY; EUROPE; GENOMICS; HOMOZYGOTE; HUMANS; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC; PATHOLOGY; PHENOTYPE;

EID: 60149112627     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0109-24     Document Type: Letter

References (7)

1. Ince, T.A. et al. Nat. Biotechnol. 26, 978-979 (2008).
2. Barthold, S.W. et al. J. Vet. Diagn. Invest. 19, 455-456 (2007).
3. Warren, M.V. et al. J. Pathol. 217, 4-13 (2009).
4. Cardiff, R.D., Ward, J.M. & Barthold, S.W. Lab. Invest. 88, 18-26 (2008).
5. Austin, C.P. et al. Nat. Genet. 36, 921-924 (2004).
6. Collins, F.S., Rossant, J. & Wurst, W. Cell 128, 9-13 (2007).
7. Brayton, C. in The Mouse in Biomedical Research (eds. Fox, J.G. et al.) 623-717 (Academic Press, New York, 2007).